Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Noel

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Therapeutic Innovation & Regulatory Science|April 3, 2021
Inclusion of Adolescents in Adult Clinical Trials: Report of the Institute for Advanced Clinical Trials for Children's Pediatric Innovation Research ForumGary J Noel, Robert M Nelson, Christina Bucci-Rechtweg, et al.
Journal of Clinical Pharmacology|January 14, 2005
Levofloxacin pharmacokinetics in childrenShuchean Chien, Thomas G Wells, Jeffrey L Blumer, et al.
Plos One|March 14, 2013
Children's medicines in Tanzania: a national survey of administration practices and preferencesLisa V Adams, Sienna R Craig, Elia John Mmbaga, et al.
The Pediatric Infectious Disease Journal|May 2, 2008
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis mediaGary J Noel, Jeffrey L Blumer, Michael E Pichichero, et al.
International Journal of Antimicrobial Agents|January 11, 2012
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisationSusan C Nicholson, Tobias Welte, Thomas M File, et al.
The Pediatric Infectious Disease Journal|September 29, 2007
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disordersGary J Noel, John S Bradley, Ralph E Kauffman, et al.
Bulletin of the World Health Organization|December 5, 2022
Antibiotics needed to treat multidrug-resistant infections in neonatesPhoebe Cm Williams, Shamim A Qazi, Ramesh Agarwal, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2009
Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiproleKeith A Rodvold, David P Nicolau, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project TeamCharles Knirsch, Demissie Alemayehu, Radu Botgros, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Therapeutic Innovation & Regulatory Science|April 3, 2021
Inclusion of Adolescents in Adult Clinical Trials: Report of the Institute for Advanced Clinical Trials for Children's Pediatric Innovation Research ForumGary J Noel, Robert M Nelson, Christina Bucci-Rechtweg, et al.
Journal of Clinical Pharmacology|January 14, 2005
Levofloxacin pharmacokinetics in childrenShuchean Chien, Thomas G Wells, Jeffrey L Blumer, et al.
Plos One|March 14, 2013
Children's medicines in Tanzania: a national survey of administration practices and preferencesLisa V Adams, Sienna R Craig, Elia John Mmbaga, et al.
The Pediatric Infectious Disease Journal|May 2, 2008
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis mediaGary J Noel, Jeffrey L Blumer, Michael E Pichichero, et al.
International Journal of Antimicrobial Agents|January 11, 2012
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisationSusan C Nicholson, Tobias Welte, Thomas M File, et al.
The Pediatric Infectious Disease Journal|September 29, 2007
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disordersGary J Noel, John S Bradley, Ralph E Kauffman, et al.
Bulletin of the World Health Organization|December 5, 2022
Antibiotics needed to treat multidrug-resistant infections in neonatesPhoebe Cm Williams, Shamim A Qazi, Ramesh Agarwal, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2009
Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiproleKeith A Rodvold, David P Nicolau, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project TeamCharles Knirsch, Demissie Alemayehu, Radu Botgros, et al.
Pageof 3